<DOC>
	<DOC>NCT01488773</DOC>
	<brief_summary>The objective of the study was to compare in real life clinical practice two treatment regimens: inhaled glucocorticosteroid + salmeterol and inhaled glucocorticosteroid + montelukast.</brief_summary>
	<brief_title>Comparison of Two Treatment Regimens in Asthmatic Patients</brief_title>
	<detailed_description>48 month pre/post retrospective repeated measures design was used to compare the level of asthma control among patients continuously treated at the Outpatient Asthma and Allergy Treatment Center, Chair of Clinical Immunology and Microbiology, Medical University of Lodz, Poland.</detailed_description>
	<mesh_term>Leukotriene Antagonists</mesh_term>
	<mesh_term>Montelukast</mesh_term>
	<mesh_term>Salmeterol Xinafoate</mesh_term>
	<criteria>Clinical diagnosis of asthma according to the WHO/GINA 2006 definition by the physicians of the Centre, backed up by detailed medical history and physical examination as well as additional spirometry and bronchodilatation test or methacholine challenge where necessary Occurrence of an index event (intervention) defined as the first prescription for salmeterol or montelukast, establishing a 12month preindex and three consecutive 12month postindex periods At least one inhaled glucocorticosteroid prescription in the preindex period, and at least one salmeterol/montelukast prescription depending on the arm in every postindex period Incomplete diagnostics</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>asthma</keyword>
	<keyword>asthma control</keyword>
	<keyword>inhaled glucocorticosteroid</keyword>
	<keyword>ICS</keyword>
	<keyword>leukotriene antagonist</keyword>
	<keyword>LTRA</keyword>
	<keyword>montelukast</keyword>
	<keyword>fluticasone</keyword>
	<keyword>salmeterol</keyword>
	<keyword>observational study</keyword>
	<keyword>repeated measures</keyword>
	<keyword>retrospective</keyword>
</DOC>